UCSF HELEN DILLER FAMILY COMPREHENSIVE CANCER CENTER

Presentations
Heritage: A phase III safety and efficacy trial of the proposed
trastuzumab biosimilar Myl-1401O versus herceptin.
Authors*: Hope S. Rugo, Abhijit Barve, Cornelius F. Waller, Miguel Hernandez-Bronchud, Jay Herson,
Jinyu Yuan, Alexey Manikhas, Igor Bondarenko, Guzel Mukhametshina, Gia Nemsadze, Joseph D. Parra,
Maria Luisa T. Abesamis Tiambeng, Kakhaber Baramidze, Charuwan Akewanlop, Ihor Vynnychenko,
Virote Sriuranpong, Gopichand Manillapalli, Sirshendu Ray, Eduardo Patricio Yanez Ruiz, Eduardo J. Pennella
Abstract #: LBA503
Presentation Date/Time: Monday, June 6: 2:15 - 2:27 PM
Location: Hall D1
Oral Abstract Session: Breast Cancer - HER2/ER
Citation: J Clin Oncol 34, 2016 (suppl; abstr LBA503)
Rugo Research Interests: Dr. Rugo, Director of Breast Oncology & Clinical Trials Education, is PI on multiple
clinical trials focusing on combining novel targeted therapeutics to improve the treatment of both early &
late stage breast cancer (BC). She also works on studies to improve supportive care for early & late stage
BC patients, including with UCSFs Advanced Breast Cancer Program. Dr. Rugo has numerous collaborations
with large academic medical centers & consortia in order to expand the novel therapies available to patients.
She was the director of the 2016 ASCO Breast Cancer Education Committee meeting, is a member of the
Alliance & is a founding member of the Breast Cancer Research Consortium where she co-leads the triple
negative working group. She is on the novel agents committee for the neoadjuvant multi-center I SPY2
trial. At UCSF, Dr. Rugo runs the Breast Forum, a bimonthly educational session for breast cancer patients,
families & friends from throughout the bay area.
http://cancer.ucsf.edu/people/profiles/rugo_hope.3648
__________________________________________________________________________
Efficacy and safety of programmed death receptor-1 (PD-1) blockade in
metastatic uveal melanoma (UM).
Authors*: Katy K. Tsai, Alexander Noor Shoushtari, Rodrigo Ramella Munhoz, Zeynep Eroglu, Josep M. Piulats,
Patrick Alexander Ott, Douglas Buckner Johnson, Jimmy Hwang, Adil Daud, Jeffrey Alan Sosman,
Richard D. Carvajal, Bartosz Chmielowski, Michael Andrew Postow, Jeffrey S. Weber, Ryan J. Sullivan,
Alain Patrick Algazi
Abstract #: 9507
Presentation Date/Time: Monday, June 6: 1:15 – 4:15PM
Location: Arie Crown Theater
Oral Abstract Session: Melanoma/Skin Cancers
Citation: J Clin Oncol 34, 2016 (suppl; abstr 9507)
*UCSF authors in bold
87